Condition: Muscle Invasive Bladder Cancer · Sponsor: Assiut University
The goal of this clinical trial is to learn if neoadjuvant chemotherapy (NAC) affects the accuracy of magnetic resonance imaging (MRI) in staging muscle-invasive bladder cancer (MIBC). This study will also assess how tissue changes induced by NAC impact MRI interpretation. The main questions it aims to answer are: Does NAC compromise the accuracy of MRI in staging MIBC? Does NAC-induced tissue change affect the reliability of MRI in tumor assessment? Researchers will compare MRI staging accuracy in MIBC patients who received NAC to those who went directly to surgery, to see if NAC impacts MRI's diagnostic performance. Participants will: Undergo MRI scanning before surgery Receive either NAC or go directly to surgery, depending on their group assignment Have their MRI results compared to histopathological outcomes after surgery
This description comes directly from the study's public registry record.
Hamza Elhashamy, MBBCh · +201028635437 · Hamza.Ahmed00099@med.aun.edu.eg
Abdelrahman Abdelshafi, MBBCh · +201123740500 · abdulrahman.18313572@med.aun.edu.eg
Always discuss trial participation with your own doctor first.
| Urology Department, Faculty of Medicine, Assiut University | Asyut, Asyut Governorate, Egypt | Not Yet Recruiting |
| Urology Department, Faculty of Medicine, Assiut University | Asyut, Asyut Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07202819